MolPort-001-792-509

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Zhejiang Hisun’s FDA import alert; a new chapter in the fight against data integrity

A few months ago, PharmaCompass covered the Health Canada request to quarantine drugs linked to lead

Mylan’s great Indian misadventure

News about Mylan N.V.’s US $ 1.6 billion cash acquisition of Agila Specialties Private Limited